Why Are Dope-addicted, Disgraced Doctors Running Our Drug Trials?

Why would a pharmaceutical company choose to have its drugs tested by a dope-addicted doctor with a flawed disciplinary record?

In a Matter investigation, award-winning journalist Peter Aldhous analyzes federal and state data to reveal the holes in the system that is meant to safeguard people taking part in clinical trials. His research identifies a string of doctors who have been disciplined for medical errors, but have since conducted research on human volunteers. The story is based in part on documents from disciplinary actions, a series of which we have made available here.

Robert Karns
Improper prescription of painkillers to patient C.C.
Failure to follow proper procedure as ringside doctor
“Grossly negligent” in care of patient S.R.
License suspended because of drug abuse
Caught prescribing drugs while license suspended
Michael Berger
Seven-year probation for errors in treating patient B.P. and other concerns
FDA notification of intention to bar him from running clinical trials
Maurice Buchbinder
Reprimanded over rough treatment of patient
Charles Runels
“Massively overdosed” two women with testosterone
FDA notification of intention to bar him from running clinical trials
Alexander Jungreis
Fined after treatment error leaves patient in a coma